In a retrospective study, peri-implantation treatment with TNF-α inhibitor increased the implantation rate and clinical pregnancy rate significantly compared with non-treated controls; however, no changes in the pregnancy rate of live birth were observed. Cochrane reviews of humans with endometriosis did not find conclusive evidence. This evidence concerns the gene TNF and endometriosis.